Cargando...
Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo
miR-101–3p may play a therapeutic role in various tumours. However, its anti-tumour mechanism remains unclear, and a definitive strategy to treat tumour cells in vivo is lacking. The objective of this study was to investigate the inhibitory mechanism of miR-101–3p on tumour cells and to develop rele...
Gardado en:
| Publicado en: | Redox Biol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8113035/ https://ncbi.nlm.nih.gov/pubmed/33674250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2021.101908 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|